PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Varani K et al. – A2A and A3 receptor up–regulation in ERA patients and in MTX–treated RA patients was associated with high levels of TNFalpha and NF–kappaB activation. Treatment with anti–TNFalpha normalized A2A and A3 receptor expression and functionality. This new evidence of A2A and A3 receptor involvement opens the possibility of exploiting their potential role in human diseases characterized by a marked inflammatory component.

   

Related Articles

Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09    Relevance Score: 71%

Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09    Relevance Score: 70%

Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09    Relevance Score: 70%

Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09    Relevance Score: 69%

Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09    Relevance Score: 69%

Today in Rheumatology...keeping you current

Rheumatic heart disease and its control in the Pacific
Expert Review of Cardiovascular Therapy , 12/14/09

Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
Open Access Rheumatology: Research and Reviews, 12/14/09

Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix(R)) injections versus local anesthetic in osteoarthritis of the hip
Arthritis Research & Therapy, 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address